# Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC

> **NCT06598761** · — · RECRUITING · sponsor: **Peking University First Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Ureter Cancer
- Renal Pelvic Carcinoma
- Advanced Urothelial Carcinoma

## Interventions

- **COMBINATION_PRODUCT:** Immunotherapy+radiotherapy
- **OTHER:** surveillance alone

## Key facts

- **NCT ID:** NCT06598761
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-08-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06598761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06598761, "Postoperative Adjuvant Immunotherapy Combined with Radiotherapy Versus Surgery Alone in Locally Advanced UTUC". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06598761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*